Cargando…
Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19
BACKGROUND: We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. METHODS: The records of 49 COVID-19 patients who were admitted to an inten...
Autores principales: | Zhang, Dong, Li, Liubing, Chen, Yu, Ma, Jie, Yang, Yanli, Aodeng, Surita, Cui, Qiuju, Wen, Kedi, Xiao, Meng, Xie, Jing, Xu, Yingchun, Li, Yongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640509/ https://www.ncbi.nlm.nih.gov/pubmed/34861818 http://dx.doi.org/10.1186/s10020-021-00412-1 |
Ejemplares similares
-
Syndecan‐4, a model proteoglycan to study endothelial glycocalyx mechanosensing and signal transduction
por: van den Berg, Bernard M.
Publicado: (2019) -
Measuring the Concentration of Serum Syndecan-1 to Assess Vascular Endothelial Glycocalyx Injury During Hemodialysis
por: Kusuzawa, Keigo, et al.
Publicado: (2021) -
High Preoperative Serum Syndecan-1, a Marker of Endothelial Glycocalyx Degradation, and Severe Acute Kidney Injury after Valvular Heart Surgery
por: Kim, Hye-Bin, et al.
Publicado: (2020) -
Endothelial Glycocalyx Degradation in Critical Illness and Injury
por: Patterson, Eric K., et al.
Publicado: (2022) -
Endothelial glycocalyx degradation during sepsis: Causes and consequences
por: Sullivan, Ryan C., et al.
Publicado: (2021)